Global Rosuvastatin Market Growth 2025-2031

Global Rosuvastatin Market Growth 2025-2031

The global Rosuvastatin market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Rosuvastatin medication is a statin that is used to lower bad cholesterol and prevent cardiovascular disease. It works by blocking an enzyme in the liver that makes cholesterol. It is taken by mouth and should be used together with dietary changes, exercise, and weight loss. It may also raise good cholesterol and lower triglycerides. It is sold under the brand name Crestor among others. It may be used when other statins have not worked well.

United States market for Rosuvastatin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Rosuvastatin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Rosuvastatin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Rosuvastatin players cover AstraZeneca, Teva Pharmaceutical Industries, MSN Laboratories, Cadila Pharmaceuticals, LGM Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Rosuvastatin Industry Forecast” looks at past sales and reviews total world Rosuvastatin sales in 2024, providing a comprehensive analysis by region and market sector of projected Rosuvastatin sales for 2025 through 2031. With Rosuvastatin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rosuvastatin industry.

This Insight Report provides a comprehensive analysis of the global Rosuvastatin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Rosuvastatin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Rosuvastatin market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rosuvastatin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rosuvastatin.

This report presents a comprehensive overview, market shares, and growth opportunities of Rosuvastatin market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Purity 98.0%
Purity 99.0%
Other

Segmentation by Application:
Tablet
Capsule
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
AstraZeneca
Teva Pharmaceutical Industries
MSN Laboratories
Cadila Pharmaceuticals
LGM Pharma
Bal Pharma
Changzhou Pharmaceutical Factory
Jingxin Pharm
Zhejiang Hisun Pharmaceutical
HEC Pharm
Lunan Pharmaceutical
Nanjing Frochem Tech
Lianyungang Runzhong Pharmaceutical
Shandong Bechem Chemicals
CTX Life Sciences

Key Questions Addressed in this Report

What is the 10-year outlook for the global Rosuvastatin market?

What factors are driving Rosuvastatin market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Rosuvastatin market opportunities vary by end market size?

How does Rosuvastatin break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.